SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-074889
Filing Date
2020-03-16
Accepted
2020-03-16 16:17:01
Documents
5
Period of Report
2020-04-28
Effectiveness Date
2020-03-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d861805ddef14a.htm DEF 14A 1469032
2 GRAPHIC g861805g0315212854430.jpg GRAPHIC 2591
3 GRAPHIC g861805g10v55.jpg GRAPHIC 30818
4 GRAPHIC g861805g16f81.jpg GRAPHIC 24487
5 GRAPHIC g861805g69b62.jpg GRAPHIC 37433
  Complete submission text file 0001193125-20-074889.txt   1595855
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14956 | Film No.: 20717339
SIC: 2834 Pharmaceutical Preparations